Showing results (2071-2080 of 8,887) with videos related to

Sort By:
Pageof 889
European Urology|March 28, 2025
A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive TreatmentElio Mazzone, Donato Cannoletta, Leonardo Quarta, et al.
European Urology|April 12, 2025
Stereotactic Body Radiation Therapy Alone or in Combination with Immunotherapy in Kidney Cancer: A Systematic ReviewNora Sundahl, Laurence Albiges, Toni K Choueiri, et al.
European Urology|June 9, 2023
Differing Recommendations on Prostate Biopsy Approach to Minimize Infections: An Examination of the European Association of Urology and American Urological Association GuidelinesElie Kaplan-Marans, Tenny R Zhang, Jim C Hu
European Urology|June 5, 2023
Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 StudyWassim Abida, David Campbell, Akash Patnaik, et al.
European Urology|May 27, 2023
Are PARP Inhibitors Ready for Prime Time in Metastatic Prostate Cancer? Maybe NotDaniel A González-Padilla, José Daniel Subiela
European Urology|February 19, 2026
Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT StudyElizabeth K Bancroft, Elizabeth C Page, Jana McHugh, et al.
European Urology|March 1, 2026
KIM-1 and Circulating Tumor DNA Are Prognostic Markers for Oligometastatic Clear-cell Renal Cell Carcinoma: Development of a Multivariable Prognostic ModelChad Tang, Aaron Seo, Alexander D Sherry, et al.
European Urology|June 28, 2023
Identification of Lineage-specific Transcriptional Factor-defined Molecular Subtypes in Small Cell Bladder CancerMingxiao Feng, Andres Matoso, Gabriel Epstein, et al.
European Urology|March 31, 2024
PRECISE Version 2: Updated Recommendations for Reporting Prostate Magnetic Resonance Imaging in Patients on Active Surveillance for Prostate CancerCameron Englman, Davide Maffei, Clare Allen, et al.
European Urology|March 23, 2024
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 StudyRoberto Iacovelli, Chiara Ciccarese, Sebastiano Buti, et al.
Pageof 889